(Total Views: 715)
Posted On: 12/20/2020 10:03:29 AM
Post# of 153940
Real good data . From the UCLA eind study
Of the 23, 7 required mechanical ventilation at the time of leronlimab dosing. Of these critically ill patients, 6 of 7 were alive after more than 70 days, a substantially higher survival rate than other reports of critically ill COVID-19 patients [19–22], which range from 42% to 61% in cohorts followed about 30 days after hospitalization. Of the 15 with milder (but still “severe” as defined by supplemental oxygen requirement) illness, 13 no longer required further acute hospital care by 30 days. Thus, the overall outcomes for this high-risk group of patients were better than historically observed in multiple reports from the same time frame.
Of the 23, 7 required mechanical ventilation at the time of leronlimab dosing. Of these critically ill patients, 6 of 7 were alive after more than 70 days, a substantially higher survival rate than other reports of critically ill COVID-19 patients [19–22], which range from 42% to 61% in cohorts followed about 30 days after hospitalization. Of the 15 with milder (but still “severe” as defined by supplemental oxygen requirement) illness, 13 no longer required further acute hospital care by 30 days. Thus, the overall outcomes for this high-risk group of patients were better than historically observed in multiple reports from the same time frame.
(2)
(0)
